Browse

The U.S. Food and Drug Administration has given Capricor Therapeutics an additional three months to evaluate its Duchenne muscular dystrophy cell therapy after the agency asked for more information…

Labcorp is looking to plug the gap in hepatitis D monitoring with a new reflex testing solution to help find more patients with this form of the virus earlier.